Prelude Therapeutics lands $60 million in Series B funding - Technical.ly Delaware

Sciences

Jun. 26, 2019 1:42 pm

Prelude Therapeutics lands $60 million in Series B funding

The company plans to enter preclinical development on its cancer drug therapies this year.
Test tubes in a wet lab.

Test tubes in a wet lab.

(Photo by Pexels user Martin Lopez used under a Creative Commons license)

Wilmington-based Prelude Therapeutics, a biotech startup that launched in 2016, has secured $60 million in Series B financing, DelawareBio has reported.

The financing was co-led by Prelude’s two existing institutional investors, including OrbiMed Advisors LLC, bringing Prelude’s total investments to date to $95 million.

Prelude is a clinical-stage biopharmaceutical company. Several of its drug discovery programs are expected to enter preclinical development this year, with a potential IND (Investigational New Drug) filing in 2020.

“We are very appreciative of the continued support of our current investors, who have been integral to the founding of Prelude and the creation of our growing pipeline,” said Kris Vaddi, PhD, Founder and CEO of Prelude Therapeutics, in a press release. “We believe PRMT5 inhibitors represent a promising new class of drugs to treat cancers, including ones that have developed resistance to existing targeted therapies. We are also pleased to have assembled such a talented, experienced and proven leadership team to address some of the most pressing gaps in cancer treatment.”

Dr. Vaddi was previously a member of the founding team of Incyte Corporation in 2002. He initiated JAK (Janus kinase, enzymes that have been discovered to play role in the body’s immune defense) research programs at Incyte that led to Jakafi (ruxolotinib) for myelofibrosis and polycythemia vera and Olumiant (Baricitinib) for rheumatoid arthritis.

-30-
CONTRIBUTE TO THE
JOURNALISM FUND

Already a contributor? Sign in here
Connect with companies from the Technical.ly community
New call-to-action

Advertisement

How the ChristianaCare and Medtronic partnership will evolve healthcare in Delaware

Here are the biotech startups selected for the 2019 UD Fastpass

Year-end roundup: A dozen Delaware biotech stories from 2019

SPONSORED

Delaware

Technology is ever evolving — shouldn’t business education be, too?

Philadelphia, PA

Vistar Media

Software Engineer

Apply Now

Philadelphia

Urban Outfitters

Urban Outfitters: Jr. Motion Graphic Designer

Apply Now

Philadelphia

URBN

URBN: User Experience (UX) Designer

Apply Now

How virtual reality can be used to prevent opioid deaths

CRISPR gene editing in Delaware: ‘It’s bigger than just the technology’

Beebe is offering free data privacy classes for Cybersecurity Awareness Month

SPONSORED

Delaware

Packed with growth opportunities, WSFS Bank moves into Philly

Horsham

Penn Mutual Life Insurance Co

Product Systems Specialist

Apply Now

Philadelphia, PA - Center City

Odessa

Sr. Project Manager – ERP Implementations

Apply Now

Philadelphia, PA

Vistar Media

QA Engineer

Apply Now

Sign-up for daily news updates from Technical.ly Delaware

Do NOT follow this link or you will be banned from the site!